Craig Hudson

Toronto, Ontario

Dr. Craig J Hudson is a distinguished psychiatrist, medical researcher, and entrepreneur known for his innovative approach to central nervous system (CNS) research. Trained in the University of Toronto system, Dr. Hudson has spent over 30 years pursuing CNS discoveries to develop better treatments for complex mental health challenges. He is the founder of Biosential Inc., a biotechnology company which he founded in 1999. 

Early life

Born and raised in Toronto, Ontario, Canada, Craig Hudson attended University of Waterloo where he first developed an interest in research science. He earned his medical degree at the University of Toronto in 1988 and became a Fellow of the Royal College of Physicians of Canada in 1993 specializing in psychiatry. 

Career

In 1999, Craig Hudson and his wife, Susan Hudson, noticed that there was a gap in the medical research marketplace. Observing friends and colleagues struggling to launch medical businesses—many of which failed due to a lack of funding—they saw an opportunity to innovate. Dr. Hudson conceived the idea of developing a natural product with proven clinical benefits that could enter the market quickly. This approach would help Craig and Susan generate cash flow and avoid the prolonged gap between initial funding and the extended timeline often required for clinical market regulatory approvals. 

With this strategy in mind, the Hudsons decided to venture out independently, focusing on products with clear, scientifically backed benefits and rapid market access. This dual emphasis on science and speed became the foundation of Biosential Inc.’s success, positioning the company as a leader in merging rigorous research with sustainable profitability.

From the outset, the goal of Biosential Inc. was to reimagine consumer health products by blending robust scientific investigation with innovative, market-savvy approaches. Despite the challenges—both at the start and in the years that followed—Dr. Hudson and Susan were driven by their conviction that their work was both necessary and impactful.

Biosential’s mission has always been rooted in advancing scientific discovery while supporting other practitioners in the field. True to this ethos, the company has conducted extensive studies and clinical trials. One area of focus has been the protein source tryptophan and its efficacy as a sleep aid. Additionally, Dr. Hudson has explored the role of microsatellite polymorphism in schizophrenia and other neurodevelopmental disorders, contributing valuable insights to these complex fields.

This commitment to science and innovation has established Biosential as a pioneering force, bridging the gap between rigorous research and real-world applications in consumer health.

Net Worth

Craig Hudson’s net worth is currently unknown.

Achievement

Established a successful biotech company focused on developing scientifically backed consumer health products.
Pioneered the creation of natural health products with strong clinical benefits that achieve rapid market access.
Conducted research on microsatellite polymorphism and its implications for schizophrenia and other neurodevelopmental disorders.
Led clinical trials on the protein source tryptophan as an effective medicine for improving sleep.
Recognized for his contributions to psychiatry and mental health.
Successfully navigated the challenges of launching and sustaining a profitable company in the medical research and consumer health industries.
Dedicated to advancing the work of other practitioners and fostering new discoveries in mental health and neuroscience.
Created innovative strategies to address the funding-to-approval gap for medical and health products.
Authored several books and holds 26 patents.
Past recipient of the Medical Research Council Clinician Scientist Award.